Active Surveillance Cultures and Decolonization to Reduce Staphylococcus aureus Infections in the Neonatal Intensive Care Unit

Infect Control Hosp Epidemiol. 2016 Apr;37(4):381-7. doi: 10.1017/ice.2015.316. Epub 2016 Jan 4.

Abstract

Background: Staphylococcus aureus is a common cause of healthcare-associated infections in neonates.

Objective: To examine the impact of methicillin-susceptible S. aureus (MSSA) decolonization on the incidence of MSSA infection and to measure the prevalence of mupirocin resistance.

Methods: We retrospectively identified neonates admitted to a tertiary care neonatal intensive care unit (NICU) from April 1, 2011, through September 30, 2014. We compared rates of MSSA-positive cultures and infections before and after implementation of an active surveillance culture and decolonization intervention for MSSA-colonized neonates. We used 2 measurements to identify the primary outcome, NICU-attributable MSSA: (1) any culture sent during routine clinical care that grew MSSA and (2) any culture that grew MSSA and met criteria of the National Healthcare Safety Network's healthcare-associated infection surveillance definitions. S. aureus isolates were tested for mupirocin susceptibility. We estimated incidence rate ratios using interrupted time-series models.

Results: Before and after the intervention, 1,523 neonates (29,220 patient-days) and 1,195 neonates (22,045 patient-days) were admitted to the NICU, respectively. There was an immediate reduction in the mean quarterly incidence rate of NICU-attributable MSSA-positive clinical cultures of 64% (incidence rate ratio, 0.36 [95% CI, 0.19-0.70]) after implementation of the intervention, and MSSA-positive culture rates continued to decrease by 21% per quarter (incidence rate ratio, 0.79 [95% CI, 0.74-0.84]). MSSA infections also decreased by 73% immediately following the intervention implementation (incidence rate ratio, 0.27 [95% CI, 0.10-0.79]). No mupirocin resistance was detected.

Conclusion: Active surveillance cultures and decolonization may be effective in decreasing S. aureus infections in NICUs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Cross Infection / epidemiology*
  • Cross Infection / prevention & control
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Infection Control / methods
  • Intensive Care Units, Neonatal*
  • Male
  • Maryland
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Mupirocin / therapeutic use*
  • Regression Analysis
  • Retrospective Studies
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / prevention & control
  • Tertiary Healthcare

Substances

  • Anti-Bacterial Agents
  • Mupirocin